The molecule is small, cheap to synthesise, and would be difficult to defend commercially
Why it was included in the FDA ban Injectable GHK-Cu was banned because of a high risk for immune reactions and impurities during the compounding process
One COA proves the blend is pharmaceutical grade. A meaningful blend assessment requires separate identity, quantity, ratio, impurity and stability evidence
Side Effects of BPC157 BPC-157 has been studied for its potential therapeutic effects in various conditions
Patients with more severe or longstanding deficiency may take longer to notice the full benefit
Even if clinical trials suggest tolerability, the real-world risk profile changes when: the source and purity of the peptide are uncertain, its used in different routes than studied, its used in stacked protocols with other drugs, its used in populations the trials didnt represent